食品伙伴网讯 2019年6月11日，欧洲食品安全局发布消息，应欧盟委员会的要求，欧盟膳食、营养和过敏症科学小组（NDA）根据法规（EU）2015/2283就2'-岩藻糖乳糖/二岩藻糖乳糖混合物（2‐fucosyllactose/difucosyllactose mixture）作为新型食品提供科学意见。

　　据了解，这种新型食品一种粉末状混合物，主要由两种寡糖组成，主要用于包括婴儿配方奶粉、婴幼儿食品、特殊医疗食品和食品补充剂等中。经过评估，小组得出结论，在建议的目标人群使用条件下，这种新型食品是安全的。

　　部分原文报道如下：

　　Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens （NDA） was asked to deliver an opinion on 2‐fucosyllactose/difucosyllactose （2‐FL/DFL） mixture as a novel food （NF） pursuant to Regulation （EU） 2015/2283. The NF is a powdered mixture mainly composed of two oligosaccharides, 2‐FL and DFL, which are produced together by fermentation with a genetically modified strain of Escherichia coli K12. The information provided on the manufacturing process, composition and specifications of the NF does not raise safety concerns. The applicant intends to add the NF in a variety of foods, including infant and follow‐on formula, foods for infants and young children, foods for special medical purposes and food supplements. The target population is the general population except for food supplements, for which the target population is individuals above 1 year of age. Since the intake of 2‐FL and DFL from the NF at the proposed use levels is unlikely to exceed the intake level of naturally occurring 2‐FL and DFL in breastfed infants per kilogram body weight, the Panel concludes that the NF, a mixture of 2‐FL and DFL, is safe under the proposed conditions of use for the proposed target population.